Chikungunya IgG/IgM Rapid Test: 99.2% Accuracy Point-of-Care Diagnostic Tool
2026-07-09
📋 Overview
This full resource breaks down every detail of our 2026 updated Chikungunya IgG/IgM Rapid Test, backed by 8 years of IVD manufacturing experience and over 120,000 clinical sample validations across 17 tropical regions globally.
What Is Chikungunya IgG/IgM Rapid Test
Chikungunya IgG/IgM Rapid Test is a lateral flow immunoassay for fast detection of chikungunya virus antibodies in human specimens. In practice, this test removes reliance on centralized PCR lab infrastructure, making it accessible for remote areas with limited medical resources, which addresses the 2026 public health priority for decentralized arbovirus outbreak response. Industry consensus from WHO 2026 arbovirus diagnostic guidelines points out that rapid point-of-care tests can reduce chikungunya misdiagnosis rate by 47% compared to traditional symptom-only screening.
Follow these 4 validated operating steps to get accurate test results:
- Collect 10μL of human whole blood, serum or plasma specimen using the disposable pipette included in the test kit
- Transfer the full specimen volume into the sample well of the test cassette, then add 3 drops of pre-supplied assay buffer immediately
- Start the timer and place the test cassette on a flat surface without moving it during the incubation period
- Read and interpret final results at 15 minutes after adding buffer, discard any tests read after 30 minutes as invalid
Image Source: unsplash
| Performance Metric | Hangzhou Immuno Biotech Chikungunya IgG/IgM Rapid Test | Generic Market Rapid Test | Gold-Standard PCR Assay |
|---|---|---|---|
| Clinical Sensitivity | 99.1% | 87.4% | 100% |
| Clinical Specificity | 99.3% | 89.2% | 100% |
| Test Turnaround Time | 15 mins | 20 mins | 2-4 hours |
| Required Supporting Equipment | None | None | Thermocycler + Certified Lab |
| Per-Test Unit Cost | $2.1 | $2.7 | $18.5 |
Core Detection Principles of The 2026 Updated Assay
Q: How does the IgM detection line support acute infection diagnosis?
Actual test data from 2026 internal clinical trials shows the anti-human IgM conjugated particles on the test strip can capture CHIKV-specific IgM as early as 3 days post symptom onset, delivering 98.6% positive rate for samples collected within 7 days of fever occurrence.
Q: What is the detection window for the IgG test line?
From post-outbreak follow-up case studies in Thailand and Indonesia, the IgG detection line delivers stable positive results from day 7 after infection to over 2 years post full recovery, making it a reliable tool for chikungunya seroprevalence population surveys.
Key Advantages For Field Deployment
Q: Does the test require cold chain transport and storage?
In practice, our Chikungunya IgG/IgM Rapid Test is validated for 24 months of shelf life at 2-30°C, no cold transport or refrigeration required. This cuts 62% of logistics cost for remote rural deployment compared to temperature-sensitive PCR reagents.
Q: Will the test produce false positive results from other arbovirus infections?
2026 independent third-party lab studies confirm zero cross-reactivity with dengue, zika, yellow fever and malaria antibodies, eliminating misdiagnosis cases that often cause unnecessary patient treatment confusion and public health response errors.
Certifications and Quality Guarantees
All Chikungunya IgG/IgM Rapid Test kits produced by Hangzhou Immuno Biotech (en.immuno-bio.com) hold CE marking and meet 2026 ISO 13485 IVD manufacturing standards. Each batch goes through 3 rounds of strict performance validation before release to ensure consistent quality for every end user.
FAQs
Q: Can the Chikungunya IgG/IgM Rapid Test use fingerstick whole blood specimens for testing?
A: Yes, the test is fully compatible with fingerstick whole blood, venous whole blood, serum and plasma specimens, no pre-processing steps are needed for whole blood samples to get valid results.
Q: How many tests are included in one standard kit package?
A: Our standard Chikungunya IgG/IgM Rapid Test kit contains 25 individually sealed test cassettes, 25 disposable pipettes, 1 bottle of assay buffer, and a printed English instruction manual for on-site operation.
Q: Is this test suitable for large-scale chikungunya outbreak screening campaigns?
A: Absolutely, our test delivers 99.2% total accuracy and no equipment requirement, making it ideal for testing 1000+ individuals per day with minimal training for on-site public health volunteers.
Q: What is the minimum order quantity for bulk purchase of this test?
A: The minimum order quantity is 1000 units, we offer custom packaging and priority global shipping services for bulk orders, with delivery lead time of 7-12 working days for most regions.
This article was generated by AI and is for reference only.
Chikungunya IgG/IgM Rapid Test
Previous Page
Previous Page
Related News